# An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease

> **NCT05497765** · NA · COMPLETED · sponsor: **Guangzhou Medical University** · enrollment: 94 (actual)

## Conditions studied

- Nonalcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Silibinin extract, mixed power of pueraria, schisandra and salvia miltiorrhiza
- **DIETARY_SUPPLEMENT:** Silibinin extract
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05497765
- **Lead sponsor:** Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2024-01-31
- **Final completion:** 2024-02-20
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05497765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05497765, "An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05497765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*